CANCER RESEARCH Journal

•  
• Overview
•  
• Identity
•  
• View All
•  

Overview

publication venue for

• Transient Activation of the Hedgehog-Gli Pathway Rescues Radiotherapy-Induced Dry Mouth via Recovering Salivary Gland Resident Macrophages..  80:5531-5542. 2020
• A Bis-Indole-Derived NR4A1 Antagonist Induces PD-L1 Degradation and Enhances Antitumor Immunity..  80:1011-1023. 2020
• Acetylation of CCAR2 Establishes a BET/BRD9 Acetyl Switch in Response to Combined Deacetylase and Bromodomain Inhibition..  79:918-927. 2019
• Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer..  78:4459-4470. 2018
• Long-Chain n-3 Fatty Acids Attenuate Oncogenic KRas-Driven Proliferation by Altering Plasma Membrane Nanoscale Proteolipid Composition..  78:3899-3912. 2018
• PAX3-FOXO1A Expression in Rhabdomyosarcoma Is Driven by the Targetable Nuclear Receptor NR4A1..  77:732-741. 2017
• Targeted Deletion of p53 in Lgr5-Expressing Intestinal Stem Cells Promotes Colon Tumorigenesis in a Preclinical Model of Colitis-Associated Cancer..  75:5392-5397. 2015
• ERBB3-independent activation of the PI3K pathway in EGFR-mutant lung adenocarcinomas..  75:1035-1045. 2015
• Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer..  74:5184-5194. 2014
• The NADH oxidase ENOX1, a critical mediator of endothelial cell radiosensitization, is crucial for vascular development..  74:38-43. 2014
• Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer..  73:6164-6174. 2013
• Chemopreventive activity of plant flavonoid isorhamnetin in colorectal cancer is mediated by oncogenic Src and β-catenin..  73:5473-5484. 2013
• The steroid receptor coactivator-3 is required for the development of castration-resistant prostate cancer..  73:3997-4008. 2013
• FGFR1 is essential for prostate cancer progression and metastasis..  73:3716-3724. 2013
• Obesity and overfeeding affecting both tumor and systemic metabolism activates the progesterone receptor to contribute to postmenopausal breast cancer..  72:6490-6501. 2012
• In vivo diagnosis of melanoma and nonmelanoma skin cancer using oblique incidence diffuse reflectance spectrometry..  72:2738-2745. 2012
• Abstract 4007: Different expression ofAHCYL1affecting ovarian carcinogenesis between chickens and women.  72:4007-4007. 2012
• Autophagy enhanced by microtubule- and mitochondrion-associated MAP1S suppresses genome instability and hepatocarcinogenesis..  71:7537-7546. 2011
• In vivo programming of tumor antigen-specific T lymphocytes from pluripotent stem cells to promote cancer immunosurveillance..  71:4742-4747. 2011
• Abstract 1160: Integrated microRNA and mRNA expression profiling in a rat colon carcinogenesis model: Effect of a chemoprotective diet.  71:1160-1160. 2011
• Abstract 2729: Proteomic analysis reveals a network of inflammatory genes in epidermis associated with skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice.  71:2729-2729. 2011
• Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth..  71:2466-2475. 2011
• Shmt1 heterozygosity impairs folate-dependent thymidylate synthesis capacity and modifies risk of Apc(min)-mediated intestinal cancer risk..  71:2098-2107. 2011
• Abstract P4-06-06: Singleminded-2s (Sim2s) Promotes Breast Tumor Cell Differentiation and Inhibits Metastasis in MCF10DCIS.COM Cells.  70:p4-06-06-p4-06-06. 2010
• Heparanase enhances local and systemic osteolysis in multiple myeloma by upregulating the expression and secretion of RANKL..  70:8329-8338. 2010
• Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth..  70:6824-6836. 2010
• Role of peroxisome proliferator-activated receptor-gamma and its coactivator DRIP205 in cellular responses to CDDO (RTA-401) in acute myelogenous leukemia..  70:4949-4960. 2010
• Transcriptional regulation of estrogen receptor-alpha by p53 in human breast cancer cells..  69:3405-3414. 2009
• Leptin enhances cholangiocarcinoma cell growth..  68:6752-6761. 2008
• Curcumin decreases specificity protein expression in bladder cancer cells..  68:5345-5354. 2008
• Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium..  68:3495-3504. 2008
• Reduced colitis-associated colon cancer in Fat-1 (n-3 fatty acid desaturase) transgenic mice..  68:3985-3991. 2008
• Serotonin Metabolism Is Dysregulated in Cholangiocarcinoma, which Has Implications for Tumor Growth.  68:9184-9193. 2008
• Flat colorectal cancers are genetically determined and progress to invasion without going through a polypoid stage..  67:11594-11600. 2007
• Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway..  67:10782-10788. 2007
• The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells..  67:11001-11011. 2007
• The let-7 microRNA represses cell proliferation pathways in human cells..  67:7713-7722. 2007
• Docosahexaenoic acid and butyrate synergistically induce colonocyte apoptosis by enhancing mitochondrial Ca2+ accumulation..  67:5561-5568. 2007
• Regulation of vascular endothelial growth factor receptor-1 expression by specificity proteins 1, 3, and 4 in pancreatic cancer cells..  67:3286-3294. 2007
• Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors..  67:2816-2823. 2007
• Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway..  67:289-299. 2007
• Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor-dependent and nuclear receptor-independent pathways..  67:674-683. 2007
• Activation of human long interspersed nuclear element 1 retrotransposition by benzo(a)pyrene, an ubiquitous environmental carcinogen..  66:2616-2620. 2006
• 3-Methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha..  66:2459-2467. 2006
• Ectopic activity of fibroblast growth factor receptor 1 in hepatocytes accelerates hepatocarcinogenesis by driving proliferation and vascular endothelial growth factor-induced angiogenesis..  66:1481-1490. 2006
• In utero exposure of mice to dibenzo[a,l]pyrene produces lymphoma in the offspring: role of the aryl hydrocarbon receptor..  66:755-762. 2006
• Inhibition of bladder tumor growth by 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes: a new class of peroxisome proliferator-activated receptor gamma agonists..  66:412-418. 2006
• High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptor..  65:11478-11485. 2005
• Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway..  65:11001-11009. 2005
• gamma-Aminobutyric acid inhibits cholangiocarcinoma growth by cyclic AMP-dependent regulation of the protein kinase A/extracellular signal-regulated kinase 1/2 pathway..  65:11437-11446. 2005
• Mechanism of cell cycle regulation by FIP200 in human breast cancer cells..  65:6676-6684. 2005
• Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene..  65:6534-6542. 2005
• Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases..  65:5778-5784. 2005
• A novel ring-substituted diindolylmethane,1,1-bis[3'-(5-methoxyindolyl)]-1-(p-t-butylphenyl) methane, inhibits extracellular signal-regulated kinase activation and induces apoptosis in acute myelogenous leukemia..  65:2890-2898. 2005
• Folate transport gene inactivation in mice increases sensitivity to colon carcinogenesis..  65:887-897. 2005
• Erratum: Nuclear factor-B is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma (Cancer Research (September 2004) 64 (6511-6523).  64:8130. 2004
• 1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce peroxisome proliferator-activated receptor gamma-mediated growth inhibition, transactivation, and differentiation markers in colon cancer cells..  64:5994-6001. 2004
• Chemopreventive n-3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation and progression in the rat..  64:6797-6804. 2004
• Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma..  64:6511-6523. 2004
• Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells..  64:6740-6749. 2004
• A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase..  64:5767-5774. 2004
• Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors..  64:4555-4562. 2004
• Interaction of the aryl hydrocarbon receptor ligand 6-methyl-1,3,8-trichlorodibenzofuran with estrogen receptor alpha..  64:2889-2897. 2004
• Expression of base excision DNA repair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: identification of the molecular source of radicals responsible for DNA damage by peroxisome proliferators..  64:1050-1057. 2004
• Cooperation between ectopic FGFR1 and depression of FGFR2 in induction of prostatic intraepithelial neoplasia in the mouse prostate..  63:8784-8790. 2003
• Stromal cell heterogeneity in fibroblast growth factor-mediated stromal-epithelial cell cross-talk in premalignant prostate tumors..  63:4936-4944. 2003
• Caspase-8 and apoptosis-inducing factor mediate a cytochrome c-independent pathway of apoptosis in human colon cancer cells induced by the dietary phytochemical chlorophyllin..  63:1254-1261. 2003
• Peroxisome proliferator-activated receptor gamma agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor alpha in MCF-7 breast cancer cells..  63:958-964. 2003
• Microarray reveals differences in both tumors and vascular specific gene expression in de novo CD5+ and CD5- diffuse large B-cell lymphomas..  63:60-66. 2003
• Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo..  62:5571-5579. 2002
• Uridine phosphorylase (-/-) murine embryonic stem cells clarify the key role of this enzyme in the regulation of the pyrimidine salvage pathway and in the activation of fluoropyrimidines..  62:2313-2317. 2002
• Fibroblast growth factor receptor 1 phosphotyrosine 766: molecular target for prevention of progression of prostate tumors to malignancy..  62:1898-1903. 2002
• p53-dependent suppression of uridine phosphorylase gene expression through direct promoter interaction..  61:6899-6905. 2001
• A rare premalignant prostate tumor epithelial cell syndecan-1 forms a fibroblast growth factor-binding complex with progression-promoting ectopic fibroblast growth factor receptor 1..  61:5295-5302. 2001
• Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator..  61:3902-3907. 2001
• Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity..  61:1100-1106. 2001
• Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis..  61:1138-1143. 2001
• Modulation of tumor angiogenesis by stem cell factor..  60:6757-6762. 2000
• Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators..  60:4798-4803. 2000
• Genomic structure, chromosomal mapping, and promoter region analysis of murine uridine phosphorylase gene..  59:4997-5001. 1999
• Estrogen receptor activation via activation function 2 predicts agonism of xenoestrogens in normal and neoplastic cells of the uterine myometrium..  59:3090-3099. 1999
• A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity..  59:336-341. 1999
• High frequency of beta-catenin (ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat..  58:1127-1129. 1998
• Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells..  57:5369-5378. 1997
• Cancer chemopreventive activity mediated by deguelin, a naturally occurring rotenoid..  57:3424-3428. 1997
• Targeted disruption of the epidermal growth factor receptor impairs growth of squamous papillomas expressing the v-ras(Ha) oncogene but does not block in vitro keratinocyte responses to oncogenic ras..  57:3180-3188. 1997
• A novel retinoic acid receptor-selective retinoid, ALRT1550, has potent antitumor activity against human oral squamous carcinoma xenografts in nude mice..  57:162-168. 1997
• Inhibition of apoptosis in colon tumors induced in the rat by 2-amino-3-methylimidazo[4,5-f]quinoline..  56:4307-4310. 1996
• Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice..  55:3183-3191. 1995
• Dietary fat, fiber, and carcinogen alter fecal diacylglycerol composition and mass..  55:2293-2298. 1995
• Anticarcinogenic activity of indole-3-carbinol acid products: ultrasensitive bioassay by trout embryo microinjection..  54:3617-3619. 1994
• Sequence-specific interaction of a conformational domain of p53 with DNA..  53:5361-5364. 1993
• Characterization of the aryl hydrocarbon receptor and aryl hydrocarbon responsiveness in human ovarian carcinoma cell lines..  53:1802-1807. 1993
• Antiproliferative activity of a pregnancy recognition hormone, ovine trophoblast protein-1..  51:5304-5307. 1991
• Promotion of aflatoxin B1 carcinogenesis by the natural tumor modulator indole-3-carbinol: influence of dose, duration, and intermittent exposure on indole-3-carbinol promotional potency..  51:2362-2365. 1991
• Rat ovarian granulosa cell culture: a model system for the study of cell-cell communication during multistep transformation..  51:696-706. 1991
• Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds on the occupied nuclear estrogen receptor in MCF-7 human breast cancer cells..  50:3579-3584. 1990
• Linoleic acid metabolism in metastatic and nonmetastatic murine mammary tumor cells..  49:4724-4728. 1989
• Structure-dependent induction of aryl hydrocarbon hydroxylase in human breast cancer cell lines and characterization of the Ah receptor..  49:4531-4535. 1989
• Epidermal growth factor receptor protein-tyrosine kinase activity in human cell lines established from squamous carcinomas of the head and neck..  49:1130-1137. 1989
• Gene for ovarian granulosa cell tumor susceptibility, Gct, in SWXJ recombinant inbred strains of mice revealed by dehydroepiandrosterone..  48:5092-5095. 1988
• Quantitative structure-activity relationships: analysis of interactions of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 2-substituted analogues with rat, mouse, guinea pig, and hamster cytosolic receptor..  47:5108-5111. 1987
• Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients..  47:1731-1739. 1987
• Quantitative Structure-Activity Relationships: Analysis of Interactions of 2,3,7,8-Tetrachlorodibenzo-p-dioxin and 2-Substituted Analogues with Rat, Mouse, Guinea Pig, and Hamster Cytosolic Receptor1.  47:5092-5140. 1987
• Significance of 1,25-dihydroxyvitamin D3 receptor in primary breast cancers..  46:5406-5408. 1986
• Membrane lipids and enzymes of cultured high- and low-metastatic B16 melanoma variants..  44:3262-3269. 1984
• Video time-lapse microscopy of phagocytosis and intracellular fate of crystalline nickel sulfide particles in cultured mammalian cells..  42:2729-2735. 1982
• Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture..  42:1116-1119. 1982
• Frequency of 1,25-dihydroxyvitamin D3 receptor in human breast cancer..  41:5121-5124. 1981
• FREQUENCY OF 1,25-DIHYDROXYVITAMIN-D3 RECEPTOR IN HUMAN-BREAST CANCER.  41:5121-5124. 1981
• Duavee (R) improves metabolic health without increasing cancer risk: findings from a preclinical model of obesity and postmenopausal breast cancer. 2021
• Tet2 Inactivation Enhances the Antitumor Activity of Tumor-Infiltrating Lymphocytes. 2021
• Randomized trial of 12 months of omega-3 fatty acids vs placebo during a weight loss intervention in post-menopausal women at increased risk for breast cancer 2021
• Combined deacetylase and bromodomain inhibition downregulates ERCC2 and suppresses growth of metastatic colon cancer cells. 2021
• Abstract 21: Optimization of dosing regimens of sulindac in combination with erlotinib for small intestine and colorectal cancer prevention 2020
• Abstract 3477: Dietary polyphenols as epigenetic ‘reader' inhibitors 2020
• Abstract 4340: Out-of-pocket expenditure, probability of underinsurance and health services utilization among non-elderly cancer survivors 2020
• Abstract PD5-01: Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays in triple negative breast cancer 2020
• Abstract 1402: Single cell transcriptomic profiling ofex vivotumoroid models reveal therapeutic vulnerabilities of pancreatic ductal adenocarcinoma 2019
• Abstract 2406: A general probabilistic algorithm to predict de novo mutations in familial diseases as demonstrated in Li-Fraumeni Syndrome 2019
• Abstract 5074: Optimizing erlotinib plus sulindac dosing regimens in a preclinical model of FAP 2019
• Abstract P6-14-03: Metastatic breast cancer alliance's patient education and access to trials: Perceptions and actions 2019
• Abstract 1661: Discovery of potent Abelson kinase inhibitors from the scaffold of pyrano[2,3-d]pyrimidin-7-one 2018
• Abstract 4646: Pharmacogenomic screen identifiesKMT2Dmutations as a biomarker of sensitivity to Aurora kinase inhibition in head and neck and cervical squamous cell carcinoma 2018
• Abstract 5401: Dysregulated microRNAs in aflatoxin-induced hepatocellular carcinoma: Serum miR-182 as a potential predictive biomarker 2018
• Abstract LB-237: Circadian dysregulation via exposure to light at night alters DNA methylation of cancer-associated genes in murine mammary tissue 2018
• Abstract 1542: Identifying genetic modifiers ofPTENusing the Collaborative Cross mouse panel 2017
• Abstract 179: Plasma membrane lipid therapy: disruption of oncogenic Ras spatiotemporal organization by membrane-targeted dietary bioactives (MTDB) 2017
• Abstract 255: Dietary amphiphilic polyphenols modulate the biophysical properties of plasma membrane organization and membrane-dependent macropinocytosis 2017
• Abstract 3400: Progression of epidermal growth factor receptor (EGFR)-independent colorectal cancer 2017
• Abstract A15: Progression of colorectal cancer through epidermal growth factor receptor (EGFR)-independent mechanisms 2017
• Abstract LB-039: Genetic dissection of mechanisms underlying epidermal growth factor receptor-independent colorectal cancer development 2016
• Abstract P2-05-23: TWIST1 silences FOXA1 transcription to promote breast cancer progression 2016
• Abstract B36: NF-kappaB-dependent and -independent roles for NIK in regulating GBM cell invasion 2015
• Abstract 1041: PTHrP(12-48) localization is intracellular and it inhibits cell proliferation and osteoclastogenesis 2015
• Abstract 3742: The influence of masculinity, racism, and social support on colorectal cancer screening uptake among African American men: A systematic review 2015
• Abstract LB-098: Antitumor studies: Design, synthesis, antitumor activity and molecular docking study of novel 2-deoxo-2-substituted-5-deazaalloxazines 2015
• Abstract 4291: An optimized therapeutic nanoparticle delivery platform of miRNA in preclinical murine models of malignancy 2015
• Abstract 265: Early life exposure to air pollution and promoter methylation in breast tumors in the Western New York Exposures and Breast Cancer Study 2014
• Abstract 5169: Diagnostic yield of clinical tumor and germline exome sequencing for newly diagnosed children with solid tumors 2014
• Abstract SY04-02: Dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner 2014
• Abstract 3464: CEBPD (C/EBP) acts as a tumor suppressor in hormone receptor positive breast cancer cells and may serve as biomarker to predict the need for adjuvant therapy. 2013
• Abstract P5-07-03: Gallotannins and Gallic acid From Mango Fruit (Mangifera Indica L) Suppress Breast Cancer Tumor Growth by Targeting Phosphatidylinositol3-kinase (PI3K)-Akt-NF-kB Pathway and Associated microRNAs 2012
• Abstract 3296: SRC-3 is a critical mediator in the development of castration-resistant prostate cancer 2012
• Abstract 5430: Analysis of genome-wide DNA methylation in CCRF-CEM cells confirms hypermethylation at reported epigenetic markers of T-cell lymphoblastic leukemia and identifies novel therapeutic targets with reduced methylation upon treatment with dietary indoles 2012
• Abstract LB-184: Differential effects of sulforaphane and related isothiocyanates on HDAC turnover and the DNA damage response in colon cancer cells 2012
• P4-16-01: Proteomic Analysis of Patient Plasma Identifies Parathyroid Hormone Related Protein (PTHrP12-48) as a Potential Biomarker of Breast Cancer Bone Metastasis. 2011
• Abstract 1928: Travel distance and pattern of care for laryngeal cancer in Kentucky 2011
• Abstract 476: Defining two populations of prostate cancer cells with distinct molecular, biological, and tumor-propagating properties 2011
• Abstract 702: Drug resistance and invasion in diffuse large B-cell lymphoma are mediated by Akt, 14-3-3, and Vimentin 2011
• Abstract 2126: Quantitative trait locus analysis of tumor morphology in a mouse model of human colorectal cancer 2010
• Abstract 276: Docosahexaenoic acid alters the spatio-temporal segregation and activation of EGF receptor 2010
• Abstract 4210: Gsta4 modifies susceptibility to skin tumor development in mice and humans 2010
• Abstract 955: n-3 polyunsaturated fatty acids promote apoptosis in oxidatively stressed transgenic mouse models 2010
• Abstract 72: Metformin enhances tumor regression and reduces tumor burden in a preclinical paradigm modeling obesity's impact on postmenopausal breast cancer 2010
• Dysregulated eicosanoid signaling associated with COX-2 overexpression in the BK5.COX-2 mouse model of pancreatic cancer 2009
• Histone deacetylase inhibitor induces autophagy through targeting mitochondria 2009
• Bub1 up-regulation and hyper-phosphorylation are major features promoting malignant transformation in SV40 Tag -induced transgenic mouse models 2006
• Characterization of EGFR-independent signaling pathways in ApcMin tumors 2006
• Characterization of proliferative responses of rat lymphatic endothelial cells RMLEC in vitro 2006
• Colonic cyclopurines induced by azoxymethane and irradiation are decreased by dietary fish oil 2006
• Diverse tumor promoting agents induce epidermal Glutathione S-transferase alpha 4 (Gsta4) levels in tumor promotion resistant C57BL/6 mice 2006
• Growth inhibitory and differentiating effects of anthocyanin-enriched fruit extracts on colon cancer cells 2006
• Identifying resistance modifiers of azoxymethane induced colon cancer. 2006
• Regulation of Stat3 gene transcription by triplex-forming oliogonucleotides in mice 2006
• Role of IGFBP-3 in the proliferation of MDA-MB-231 breast carcinoma cells in bone metastasis 2006
• TPA-induced expression of the Nmes1 homolog in mouse epidermis is associated with resistance to skin tumor promotion 2006

Identity

International Standard Serial Number (ISSN)

• 0008-5472